SANUWAVE Reports 61% Revenue Growth Despite Increased Net Losses in Q1 2025 Financial Results

SANUWAVE Health, Inc. (OTCBB: SNWV) has recently reported its financial results for the first quarter ended March 31, 2025, showcasing mixed outcomes concerning growth and losses.

Positive Aspects from the Income Statement:

• Revenue Growth: Total revenue increased by 61%, reaching $9.3 million for Q1 2025, compared to $5.8 million in Q1 2024. This notable growth was largely driven by higher sales of the UltraMIST® system and related disposables.
• Gross Margin Improvement: The gross margin improved to 79%, up from 73% in the previous year, attributed to enhanced pricing initiatives on UltraMIST® products.
• Operating Income: The company reported an operating income of $986,000 for Q1 2025, a significant turnaround from an operating loss of $1 million in Q1 2024.

Negative Aspects from the Income Statement:

• Net Loss: Despite revenue growth, the net loss widened to $5.7 million in Q1 2025 from $4.5 million a year earlier. This increase is largely due to a rise in the loss associated with the change in the fair value of derivative liabilities.
• Significant Other Expenses: Total other expenses surged to $6.6 million, influenced by decreased other income and a substantial increase in the liability valuations.
• Recurring Financial Challenges: The company continues to face a significant accumulated deficit of $257.1 million and negative working capital.

Key Statistics:

• Revenue: $9.3 million in Q1 2025 vs. $5.8 million in Q1 2024 (61% growth).
• Net Loss: $5.7 million for Q1 2025 compared to $4.5 million in Q1 2024.
• Gross Margin: 79% for Q1 2025 vs. 73% for Q1 2024.
• Operating Income: $986,000 for Q1 2025 vs. an operating loss of $1 million for Q1 2024.
• Total Other Expenses: $6.7 million in Q1 2025 vs. $3.5 million in Q1 2024.
• Accumulated Deficit: $257.1 million as of March 31, 2025.

Overall, SANUWAVE appears to be on a growth trajectory with its revenues significantly increasing, although it faces considerable challenges with net losses and financial liabilities.